FY2025 · ended Dec 31, 2025 · Revenue $176.03M · Filed Mar 18, 2026
Heartflow, Inc. (HTFL) files with the SEC under industry code 3841, Surgical & Medical Instruments & Apparatus. In fiscal 2025, which ended Dec 31, 2025, it reported revenue of $176.0 million and a net loss of $116.8 million. Free cash flow was -$59.0 million. As of Jun 30, 2026 it held $246.8 million in cash and investments and $27.1 million in total debt.
Revenue (TTM)
$212.07M
Net income (TTM)
$-118.37M
Operating cash flow (TTM)
$-52.23M
Free cash flow (TTM)
$-59.18M
EPS (TTM)
$-1.55
Dividend per share
None
Shares outstanding
85.76M
Net cash
$219.71M
as of Jun 30, 2026
Operating margin
-37.8%
FY 2026
Company profile
- Industry
- Surgical & Medical Instruments & Apparatus (SIC 3841)
- Listed as
- HTFL (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- San Francisco, CA
- SEC filer status
- Non-accelerated filer, Emerging growth company
- SEC CIK
- 1464521
- Former names
- Cardiovascular Simulation, Inc. (until Jun 14, 2010)
Other Surgical & Medical Instruments & Apparatus companies
- Stryker Corp SYK
- 3M Co MMM
- Boston Scientific Corp BSX
- Becton Dickinson & Co BDX
- Medline Inc. MDLN
- Resmed Inc RMD
- Dexcom Inc DXCM
- Fresenius SE & Co. KGaA FSNUY
All 151 Surgical & Medical Instruments & Apparatus companies
Key figures
Fiscal-year totals from the annual reports. Balance sheet lines are as of each year end.
| Line | FY 2025 Dec 31, 2025 |
|---|---|
| Revenue | $176.0M |
| Operating income | -$64.1M |
| Net income | -$116.8M |
| Diluted EPS | -$3.17 |
| Operating cash flow | -$54.0M |
| Free cash flow | -$59.0M |
| Total assets | $359.5M |
| Total liabilities | $58.8M |
| Stockholders' equity | $300.6M |
| Cash and investments | $280.2M |
| Total debt | $22.1M |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-Q | Quarterly report | Aug 13, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 13, 2026 | Aug 13, 2026 |
| 8-K |
Current report
Shareholder vote results
|
Jun 18, 2026 | Jun 16, 2026 |
| 10-Q | Quarterly report | May 14, 2026 | Mar 31, 2026 |
| 8-K |
Current report
Results of operations
|
May 14, 2026 | May 14, 2026 |
| ARS | Annual report to shareholders | Apr 29, 2026 | Dec 31, 2025 |
All 194 Heartflow, Inc. SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.